Skip to main content

Advertisement

Fig. 2 | Clinical Proteomics

Fig. 2

From: Differential Plasma Glycoproteome of p19ARF Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform

Fig. 2

PCA plot of the clustering of the 20 LC-MS runs for two different disease states are linearly separated. Each data point is annotated with a number representing the order in which the samples were analyzed, followed by a letter, N or T, which indicate normal and tumor-bearing mice, respectively. In this plot, the first principal component represents 25% and the second principal component represents 17% of the total variance

Back to article page